Ronald A. DePinho 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-02 09:04 am Purchase |
2025-04-15 | 13G | Cara Therapeutics, Inc. CARA |
Ronald A. DePinho | 780,990 8.300% |
780,990 (New Position) |
Filing |